Latest Blogs

Guest Commentary
Mar 21, 2023
My Journey Through the Hematology / Oncology Fellowship Match
Dr. Michael LaPelusa shares his recent start-to-finish experience going through the Fellowship Match, with tips for preparing your application, interviewing, and telling your unique professional story.
Guest Commentary
Mar 16, 2023
Set Up Your Collaborative Team for Success: A Guideline for Advanced Practice Provider/Physician Team-Based Care in Oncology
Clear expectations are key for effective teamwork. Tammy Triglianos, Dr. Ethan Basch, and Dr. Matthew Milowsky share a guidance document to facilitate excellent collaboration in advanced practice provider/physician teams.
Guest Commentary
Mar 14, 2023
Geriatric Oncology: A Training Opportunity That Has Come of Age
Four geriatric oncology experts answer five questions about the field, including what oncology trainees need to know, how to pursue consolidated training, and why geriatric oncology is a meaningful and rewarding career.
International Perspectives
Mar 14, 2023
I Travel for Global Oncology: The Tale of My Great Journey at the University of Lahore in Pakistan
Dr. Khalid El Bairi was invited to participate in the International Summit of Health Professionals in Pakistan, a country he only knew from the news and nature documentaries. The visit challenged his perceptions and allowed him to make valuable connections.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Disclosure.

Jun 04, 2020
Warm Wishes to Rich: ASCO Chief Medical Officer Dr. Richard L. Schilsky to Retire in February 2021
A spirit of clinically relevant discovery and accessible, understandable knowledge dissemination is the profound legacy, responsibility, and obligation that Rich will leave at ASCO, and we will honor him by continuing this work at the level of rigor and quality he established.
May 26, 2020
Drug Repository Programs: A Conversation With Dr. Ray Page
Dr. Ray Page and I discuss the important role that drug repository programs can play in helping our patients afford their treatment while reducing the financial toll on the cancer care delivery system.
May 20, 2020
New ASCO Registry Helps Cancer Community Learn About COVID-19’s Impact on Cancer Care
We have an urgent need to learn more about how COVID-19 is directly and indirectly affecting the people with cancer whom we serve.
Apr 20, 2020
CAR T-Cell Therapy: A Conversation With Dr. Jason Westin
Dr. Jason Westin explains the science behind the transformative CAR T-cell therapy, and the financial concern it presents to our health care system and our patients.
Apr 07, 2020
The Power of mCODE: A Conversation With Dr. Robert Miller
Dr. Robert Miller and I discuss electronic medical records, interoperability, and ASCO's role in developing a set of standardized data elements for oncology.
Mar 10, 2020
Cancer Advance of the Year: A Conversation With Dr. Richard L. Schilsky
ASCO's chief medical officer Dr. Richard L. Schilsky and I discuss the refinement of cancer surgery, the critical importance of federally funded research, and ASCO's research priorities for the oncology community.

Pages